Literature DB >> 19060020

Myasthenic crisis.

A Chaudhuri1, P O Behan.   

Abstract

Myasthenic crisis is a life-threatening medical emergency requiring early diagnosis and respiratory assistance. It can affect between one-fifth and one-third of all patients with generalized autoimmune myasthenia gravis. Myasthenic crisis is to be distinguished from other causes of acute neuromuscular paralysis which in most cases, can be achieved clinically. High dose corticosteroids in combination with plasma exchange or immunoglobulin are the cornerstone of treatment for this fully reversible cause of neuromuscular paralysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060020     DOI: 10.1093/qjmed/hcn152

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  27 in total

Review 1.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

3.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

4.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

5.  Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.

Authors:  J Gamez
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 6.  Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors:  Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-01-22

Review 7.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

8.  7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Authors:  M C Dalakas; W N Löscher
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  Predictors of outcome of myasthenic crisis.

Authors:  J Kalita; A K Kohat; U K Misra
Journal:  Neurol Sci       Date:  2014-02-05       Impact factor: 3.307

10.  A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.

Authors:  Jeannine M Heckmann; Amanullah Rawoot; Kathleen Bateman; Rudi Renison; Motasim Badri
Journal:  BMC Neurol       Date:  2011-08-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.